Skip to main content
SpringerLink
Log in

Magnetic Resonance Spectroscopy for Monitoring Neuronal Integrity in Amyotrophic Lateral Sclerosis

  • Conference paper
N-Acetylaspartate

Part of the book series: Advances in Experimental Medicine and Biology ((volume 576))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 229.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

8. References

  1. Martin, J.E. and Swash, M. The pathology of motor neuron disease. In: Motor Neuron Disease. Biology and Management., edited by Leigh, P.N. and Swash, M. London: Springer-Verlag, 1995, p. 93–118.

    Google Scholar 

  2. B.R. Brooks, R.G. Miller, M. Swash and T.L. Munsat, El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis, Amyotroph Lateral Scler Other Motor Neuron Disord 1(5), 293–299 (2000).

    Article  PubMed  CAS  Google Scholar 

  3. C. Lomen-Hoerth, J. Murphy, S. Langmore, et al, Are amyotrophic lateral sclerosis patients cognitively normal? Neurology 60(7), 1094–1097 (2003).

    PubMed  CAS  Google Scholar 

  4. Amyotrophic Lateral Sclerosis, edited by H. Mitsumoto, D. Chad, and E.P. Pioro: Philadelphia: F.A. Davis Company, 1998.

    Google Scholar 

  5. L. Lacomblez, G. Bensimon, P.N. Leigh, P. Guillet and V. Meininger, Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II, Lancet 347(9013), 1425–1431 (1996).

    PubMed  CAS  Google Scholar 

  6. B. Brownell, D.R. Oppenheimer and J.T. Hughes, The central nervous system in motor neurone disease, J Neurol Neurosurg Psychiatry 33(3), 338–357 (1970).

    PubMed  CAS  Google Scholar 

  7. T. Lawyer and M.G. Netsky, Amyotrophic lateral sclerosis: a clinicoanatomic study of fifty-three cases, Arch Neurol Psychiatry 69, 171–192 (1953).

    Google Scholar 

  8. D.K. Leung DK, A.P. Hays, K. Geysu, M.L. DelBene and L.P. Rowland, Diagnosis of ALS: clinicopathologic analysis of 76 autopsies, Neurology 52(Suppl 2), A164 (1999).

    Google Scholar 

  9. P.G. Ince, J. Evans, M. Knopp, et al, Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS, Neurology 60(8), 1252–1258 (2003).

    PubMed  CAS  Google Scholar 

  10. S. Kalra and D. Arnold, Neuroimaging in amyotrophic lateral sclerosis, Amyotroph Lateral Scler Other Motor Neuron Disord 4(4), 243–248 (2003).

    Article  PubMed  Google Scholar 

  11. M.L. Simmons, C.G. Frondoza and J.T. Coyle, Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies, Neuroscience 45(1), 37–45 (1991).

    Article  PubMed  CAS  Google Scholar 

  12. J.R. Moffett, M.A. Namboodiri, C.B. Cangro and J.H. Neale, Immunohistochemical localization of Nacetylaspartate in rat brain, Neuroreport 2(3), 131–134 (1991).

    PubMed  CAS  Google Scholar 

  13. J. Battistuta, C. Bjartmar and B.D. Trapp, Postmortem degradation of N-acetyl aspartate and N-acetyl aspartylglutamate: an HPLC analysis of different rat CNS regions, Neurochem Res 26(6), 695–702 (2001).

    Article  PubMed  CAS  Google Scholar 

  14. O. Gredal, S. Rosenbaum, S. Topp, et al, Quantification of brain metabolites in amyotrophic lateral sclerosis by localized proton magnetic resonance spectroscopy, Neurology 48(4), 878–881 (1997).

    PubMed  CAS  Google Scholar 

  15. B.C. Bowen, P.M. Pattany, W.G. Bradley, et al, MR imaging and localized proton spectroscopy of the precentral gyrus in amyotrophic lateral sclerosis, AJNR Am J Neuroradiol 21(4), 647–658 (2000).

    PubMed  CAS  Google Scholar 

  16. C. Pohl, W. Block, J. Karitzky, et al, Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis, Arch Neurol 58(5), 729–735 (2001).

    Article  PubMed  CAS  Google Scholar 

  17. P. Sarchielli, G.P. Pelliccioli, R. Tarducci, et al, Magnetic resonance imaging and 1H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis, Neuroradiology 43(3), 189–197 (2001).

    Article  PubMed  CAS  Google Scholar 

  18. E.P. Pioro, J.P. Antel, N.R. Cashman and D.L. Arnold, Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo, Neurology 44(10), 1933–1938 (1994).

    PubMed  CAS  Google Scholar 

  19. A.P. Jones, W.J. Gunawardena, C.M. Coutinho, et al, Preliminary results of proton magnetic resonance spectroscopy in motor neurone disease (amyotrophic lateral sclerosis), J Neurol Sci 129Suppl 85–89 (1995).

    Article  PubMed  Google Scholar 

  20. M. Giroud, P. Walker, D. Bernard, et al, Reduced brain N-acetyl-aspartate in frontal lobes suggests neuronal loss in patients with amyotrophic lateral sclerosis, Neurological Research 18(3), 241–243 (1996).

    PubMed  CAS  Google Scholar 

  21. W.D. Rooney, R.G. Miller, D. Gelinas, et al, Decreased N-acetylaspartate in motor cortex and corticospinal tract in ALS, Neurology 50(6), 1800–1805 (1998).

    PubMed  CAS  Google Scholar 

  22. W. Block, J. Karitzky, F. Traber, et al, Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease: subgroup analysis and follow-up measurements, Arch Neurol 55(7), 931–936 (1998).

    Article  PubMed  CAS  Google Scholar 

  23. M.J. Strong, G.M. Grace, J.B. Orange, et al, A prospective study of cognitive impairment in ALS, Neurology 53(8), 1665–1670 (1999).

    PubMed  CAS  Google Scholar 

  24. S. Vielhaber, J. Kaufmann, M. Kanowski, et al, Effect of creatine supplementation on metabolite levels in ALS motor cortices, Exp Neurol 172(2), 377–382 (2001).

    Article  PubMed  CAS  Google Scholar 

  25. N. Schuff, W.D. Rooney, R. Miller, et al, Reanalysis of multislice (1)H MRSI in amyotrophic lateral sclerosis, Magn Reson Med 45(3), 513–516 (2001).

    Article  PubMed  CAS  Google Scholar 

  26. K. Abe, M. Takanashi, Y. Watanabe, et al, Decrease in N-acetylaspartate/creatine ratio in the motor area and the frontal lobe in amyotrophic lateral sclerosis, Neuroradiology 43(7), 537–541 (2001).

    Article  PubMed  CAS  Google Scholar 

  27. W. Kenn, G. Ochs, T.A. Pabst and D. Hahn, 1H spectroscopy in patients with amyotrophic lateral sclerosis, J Neuroimaging 11(3), 293–297 (2001).

    Article  PubMed  CAS  Google Scholar 

  28. C.C. Hanstock, V.A. Cwik and W.R. Martin, Reduction in metabolite transverse relation times in amyotrophic lateral sclerosis, J Neurol Sci 198, 37–41 (2002).

    Article  PubMed  CAS  Google Scholar 

  29. J. Suhy, R.G. Miller, R. Rule, et al, Early detection and longitudinal changes in amyotrophic lateral sclerosis by (1)H MRSI, Neurology 58(5), 773–779 (2002).

    PubMed  CAS  Google Scholar 

  30. V.A. Cwik, C.C. Hanstock, P.S. Allen and W.R. Martin, Estimation of brainstem neuronal loss in amyotrophic lateral sclerosis with in vivo proton magnetic resonance spectroscopy, Neurology 50(1), 72–77 (1998).

    PubMed  CAS  Google Scholar 

  31. S. Kalra, A. Genge and D. Arnold, A prospective, randomized, placebo-controlled evaluation of corticoneuronal response to intrathecal BDNF therapy in ALS using magnetic resonance spectroscopy: feasibility and results, Amyotroph Lateral Scler Other Motor Neuron Disord 4(1), 22–26 (2003).

    Article  PubMed  CAS  Google Scholar 

  32. S. Kalra, N.R. Cashman, Z. Caramanos, A. Genge and D.L. Arnold, Gabapentin therapy for amyotrophic lateral sclerosis: lack of improvement in neuronal integrity shown by MR spectroscopy, Am J Neuroradiol 24(3), 476–480 (2003).

    PubMed  Google Scholar 

  33. E.P. Pioro, A.W. Majors, H. Mitsumoto, D.R. Nelson and T.C. Ng, 1H-MRS evidence of neurodegeneration and excess glutamate + glutamine in ALS medulla, Neurology 53(1), 71–79 (1999).

    PubMed  CAS  Google Scholar 

  34. Parent, A. Carpenter’s Human Neuroanatomy, Baltimore: Williams and Wilkins, 1996. Ed.9 pp. 864–936.

    Google Scholar 

  35. C. Pohl, W. Block, F. Traber, et al, Proton magnetic resonance spectroscopy and transcranial magnetic stimulation for the detection of upper motor neuron degeneration in ALS patients, J Neurol Sci 190(1–2), 21–27 (2001).

    Article  PubMed  CAS  Google Scholar 

  36. C.M. Ellis, A. Simmons, C. Andrews, et al, A proton magnetic resonance spectroscopic study in ALS: correlation with clinical findings, Neurology 51(4), 1104–1109 (1998).

    PubMed  CAS  Google Scholar 

  37. V.A. Cwik, C.C. Hanstock, C. Boyd, et al, Regional neuronal dysfunction in amyotrophic lateral sclerosis (ALS): in vivo measurement with proton magnetic resonance spectroscopy (MRS), Neurology 48(Suppl 2), A216 (1997).

    Google Scholar 

  38. S. Kalra, N.R. Cashman, A. Genge and D.L. Arnold, Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy, Neuroreport 9(8), 1757–1761 (1998).

    PubMed  CAS  Google Scholar 

  39. S. Kalra, A. Genge, N.R. Cashman, and D.L. Arnold, 1H-MRSI demonstrates a regional decline in corticoneuronal integrity in amyotrophic lateral sclerosis, Amyotroph Lateral Scler Other Motor Neuron Disord 2(Suppl 2), 118–119 (2001).

    Google Scholar 

  40. Matthews P M, Cianfaglia L, McLaurin J, et al. Proceedings of the Society of Magnetic Resonance and the European Society for Magnetic Resonance in Medicine and Biology 1 147 (1995) (Abstract)

    Google Scholar 

  41. B.G. Jenkins, P. Klivenyi, E. Kustermann, et al, Nonlinear decrease over time in N-acetyl aspartate levels in the absence of neuronal loss and increases in glutamine and glucose in transgenic Huntington’s disease mice, J Neurochem 74(5), 2108–2119 (2000).

    Article  PubMed  CAS  Google Scholar 

  42. C. Gasparovic, N. Arfai, N. Smid and D.M. Feeney, Decrease and recovery of N-acetylaspartate/creatine in rat brain remote from focal injury, J Neurotrauma 18(3), 241–246 (2001).

    Article  PubMed  CAS  Google Scholar 

  43. C. Demougeot, P. Garnier, C. Mossiat, et al, N-Acetylaspartate, a marker of both cellular dysfunction and neuronal loss: its relevance to studies of acute brain injury, J Neurochem 77(2), 408–415 (2001).

    Article  PubMed  CAS  Google Scholar 

  44. N. De Stefano, P.M. Matthews and D.L. Arnold, Reversible decreases in N-acetylaspartate after acute brain injury, Magn Reson Med 34(5), 721–727 (1995).

    PubMed  Google Scholar 

  45. S. Narayanan, N. De Stefano, G.S. Francis, et al, Axonal metabolic recovery in multiple sclerosis patients treated with interferon beta-1b, J Neurol 248(11), 979–986 (2001).

    Article  PubMed  CAS  Google Scholar 

  46. M. Uno, S. Ueda, H. Hondo, K. Matsumoto and M. Harada, Effectiveness of revascularization surgery evaluated by proton magnetic resonance spectroscopy and single photon emission computed tomography, Neurol. Med. Chir. (Tokyo) 36(8), 560–566 (1996).

    Article  CAS  Google Scholar 

  47. F. Cendes, F. Andermann, F. Dubeau, P.M. Matthews and D.L. Arnold, Normalization of neuronal metabolic dysfunction after surgery for temporal lobe epilepsy. Evidence from proton MR spectroscopic imaging, Neurology 49(6), 1525–1533 (1997).

    PubMed  CAS  Google Scholar 

  48. J. Vion-Dury, F. Nicoli, A.M. Salvan, et al, Reversal of brain metabolic alterations with zidovudine detected by proton localised magnetic resonance spectroscopy, Lancet 345(8941), 60–61 (1995).

    Article  PubMed  CAS  Google Scholar 

  49. O.A. Andreassen, B.G. Jenkins, A. Dedeoglu, et al, Increases in cortical glutamate concentrations in transgenic amyotrophic lateral sclerosis mice are attenuated by creatine supplementation, J Neurochem 77(2), 383–390 (2001).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Neurology, Department of Medicine, University of Alberta, 2E3.18 WMC, 8440-112 Street, Edmonton, Alberta, T6G 2B7, Canada

    Sanjay Kalra

  2. Montreal Neurological Institute and Hospital, Department of Neurology and Neurosurgery, McGill University, 3801 University Street, Montreal, Quebec, H3A 2B4, Canada

    Douglas L. Arnold

Authors
  1. Sanjay Kalra
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Douglas L. Arnold
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Uniformed Services University of the Health Sciences, Bethesda, MD, 20814, USA

    John R. Moffett  & Aryan M. A. Namboodiri  & 

  2. University of Albany, Albany, NY, 12222, USA

    Suzannah B. Tieman

  3. National Institute of Mental Health, Bethesda, MD, 20814, USA

    Daniel R. Weinberger

  4. McLean Hospital, Belmont, MA, 02178, USA

    Joseph T. Coyle

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Science+Business Media, Inc.

About this paper

Cite this paper

Kalra, S., Arnold, D.L. (2006). Magnetic Resonance Spectroscopy for Monitoring Neuronal Integrity in Amyotrophic Lateral Sclerosis. In: Moffett, J.R., Tieman, S.B., Weinberger, D.R., Coyle, J.T., Namboodiri, A.M.A. (eds) N-Acetylaspartate. Advances in Experimental Medicine and Biology, vol 576. Springer, Boston, MA . https://doi.org/10.1007/0-387-30172-0_19

Download citation

Publish with us

Policies and ethics

Search

Navigation